Nystatin, Neomycin Sulfate, Thiostrepton, and Triamcinolone Acetonide Cream
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Nystatin, Neomycin Sulfate, Thiostrepton, and Triamcinolone Acetonide Cream contains NLT 90.0% and NMT 130.0% of the labeled amounts of nystatin, neomycin, and thiostrepton, and NLT 90.0% and NMT 110.0% of the labeled amount of triamcinolone acetonide (C24H31FO6).
2 IDENTIFICATION
2.1 A. Thin-Layer Chromatography
Standard solution: 100 µg/mL of USP Triamcinolone Acetonide RS in chloroform
Sample solution: Transfer 2 g of Cream into a conical flask, add 5.0 mL of chloroform, and shake for 10 min. Add 15 mL of alcohol, and shake for an additional 10 min. Filter the solution into a centrifuge tube, and evaporate the filtrate to dryness. Dissolve the residue in alcohol to obtain a solution containing about 250 µg/mL of triamcinolone acetonide.
Chromatographic system
(See Chromatography 〈621〉, General Procedures, Thin-Layer Chromatography.)
Mode: TLC
Adsorbent: 0.25-mm layer of chromatographic silica gel
Application volume: 10 µL
Developing solvent system: Chloroform, benzene, and methanol (5:2:1)
Spray reagent: A mixture of a 1-in-5 solution of sodium hydroxide and a 1-in-500 solution of blue tetrazolium in methanol (1:1)
Analysis
Samples: Standard solution and Sample solution
Apply the Standard solution and the Sample solution on a line parallel to and about 1.5 cm from the bottom edge of the TLC plate. Proceed as directed in the chapter and develop in the Developing solvent system until the solvent front has moved about 12 cm above the application line. Remove the plate, allow the solvent to evaporate, and spray with Spray reagent.
Acceptance criteria: The intensity of the blue color and the R_f of the spot of the Sample solution corresponds to that of the Standard solution.
3 ASSAY
3.1 Nystatin
(See Antibiotics—Microbial Assays 〈81〉.)
Standard: USP Nystatin RS
Sample stock solution: Transfer a suitable, accurately weighed portion of Cream into a blender jar. Add a sufficient, accurately measured volume of dimethylformamide and blend at high speed for 3–5 min to obtain a convenient concentration. Dilute quantitatively an accurately measured volume of the solution so obtained with dimethylformamide to obtain a stock solution containing about 400 USP Nystatin Units/mL.
Sample solution: Dilute an accurately measured volume of the Sample stock solution quantitatively with Buffer B.6 to obtain a nominal concentration of nystatin equal to the median concentration of the Standard.
Analysis: Proceed as directed for nystatin in the chapter.
Acceptance criteria: 90.0%–130.0% of the labeled amount of nystatin
3.2 Neomycin
(See Antibiotics—Microbial Assays 〈81〉.)
Standard: USP Neomycin Sulfate RS
Sample stock solution: Transfer an accurately weighed portion of Cream, equivalent to about 2.5 mg of neomycin, into a 250-mL conical flask. Add 50 mL of 0.01 N hydrochloric acid, and shake to disperse the Cream. Transfer the mixture to a 100-mL centrifuge tube. Wash the flask with 40 mL of hexanes, with shaking, and transfer the washing to the centrifuge tube. Stopper the centrifuge tube, shake, and centrifuge for 5 min. Draw off the lower aqueous layer, and transfer it to a 250-mL volumetric flask. Repeat the extraction of the hexanes layer remaining in the centrifuge tube with two 50-mL portions of 0.01 N hydrochloric acid, combining the aqueous extracts in the 250-mL volumetric flask. Dilute the contents of the volumetric flask with 0.01 N hydrochloric acid to volume, and mix.
Sample solution: Dilute the Sample stock solution quantitatively and stepwise with Buffer B.3 to obtain a nominal concentration of neomycin equal to the median concentration of the Standard.
Analysis: Proceed as directed for the turbidimetric assay for neomycin in the chapter.
Acceptance criteria: 90.0%–130.0% of the labeled amount of neomycin
3.3 Thiostrepton
(See Antibiotics—Microbial Assays 〈81〉.)
Standard: USP Thiostrepton RS
Sample stock solution: Transfer a suitable, accurately weighed portion of Cream into a blender jar. Add a sufficient, accurately measured volume of dimethyl sulfoxide, blend at high speed to obtain a convenient concentration, and filter.
Sample solution: Dilute an accurately measured volume of the Sample stock solution quantitatively with Dimethyl sulfoxide to obtain a nominal concentration of thiostrepton equal to the median concentration of the Standard.
Analysis: Proceed as directed for thiostrepton in the chapter.
Acceptance criteria: 90.0%–130.0% of the labeled amount of thiostrepton
3.4 Triamcinolone Acetonide
Mobile phase: Acetonitrile and water (approximately 30:70)
Internal standard solution: 50 µg/mL of fluoxymesterone in isopropyl alcohol
Standard stock solution: 75 µg/mL of USP Triamcinolone Acetonide RS in the Internal standard solution
Standard solution: Mix an accurately measured volume of the Standard stock solution with an equal volume of Mobile phase to obtain a solution containing about 37.5 µg/mL of USP Triamcinolone Acetonide RS.
Sample solution: Transfer an accurately weighed quantity of Cream, equivalent to about 1.5 mg of triamcinolone acetonide, to a screw-capped tube. Add 20.0 mL of the Internal standard solution, and cap securely. Heat at 60° for 5 min, and then swirl vigorously for NLT 30 s. Repeat the heating and swirling sequence 3 times. Cool in a methanol-ice bath for 15–20 min, and then centrifuge at −5° for 15 min. Dilute an accurately measured volume of the supernatant with an equal volume of Mobile phase. Cool in a methanol-ice bath for 10–15 min, with occasional agitation. Pass first through a pledget of glass wool or a prefilter disk, and then pass through a membrane of 0.45-µm pore size to obtain a clear solution.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
[Note—Adjust the operating parameters with Mobile phase, such that the separation of triamcinolone acetonide and the internal standard is optimized, with a retention time of about 14.5 min for triamcinolone acetonide.]
Mode: LC
Detector: UV 254 nm
Column: 4-mm × 30-cm; packing L1
Column temperature: Room temperature
Injection volume: 15–25 µL of equal volumes of the Standard solution and Sample solution
System suitability
Sample: Standard solution
Suitability requirements
Resolution: NLT 2.0 between the triamcinolone acetonide and fluoxymesterone peaks
Relative standard deviation: NMT 3.0% for 5 replicate injections
Analysis
Samples: Standard solution and Sample solution
Measure the peak heights of the internal standard and triamcinolone acetonide at the same retention times obtained from the Standard solution and Sample solution.
Calculate the percentage of the labeled amount of triamcinolone acetonide (C₂₄H₃₁FO₆) in the portion of Cream taken:
Result = (RU/RS) × (CS/CU) × 100
RU = peak height ratio of triamcinolone acetonide to the internal standard from the Sample solution
RS = peak height ratio of triamcinolone acetonide to the internal standard from the Standard solution
CS = concentration of USP Triamcinolone Acetonide RS in the Standard solution (mg/mL)
CU = nominal concentration of triamcinolone acetonide in the Sample solution (mg/mL)
(USP 1-Dec-2024)
Acceptance criteria: 90.0%–110.0%
4 SPECIFIC TESTS
Minimum Fill 〈755〉: Meets the requirements
5 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight containers.
Labeling: Label it to indicate that it is for veterinary use only.
USP Reference Standards 〈11〉
USP Nystatin RS
USP Neomycin Sulfate RS
USP Thiostrepton RS
USP Triamcinolone Acetonide RS

